All interventions

Pharmacological MEMANT

Memantine

Memantine is a medication primarily used to treat moderate to severe Alzheimer disease.

It works by regulating the activity of glutamate, a neurotransmitter involved in learning and memory. By blocking excessive glutamate activity at NMDA (N-methyl-D-aspartate) receptors, memantine helps to prevent neuronal damage and improve cognitive function in individuals with Alzheimer disease.

Recent studies suggest that memantine effects extend beyond Alzheimer treatment, potentially offering benefits in other neurodegenerative conditions and cognitive disorders. Its ability to modulate glutamate activity and reduce excitotoxicity indicates a broader role in neuroprotection and cognitive enhancement. This makes memantine a valuable tool in managing conditions characterized by cognitive decline and offers hope for broader applications in neuropsychiatric and neurodegenerative disorders.

Number of meta-analyses

  • Preschool (0-5): no meta-analysis
  • School-age (6-12): 31 meta-analyses
  • Adolescents (13-17): no meta-analysis
  • Adults (18+): no meta-analysis

One meta-analysis per outcome and age group, shown in the Intervention explorer.

See its evidence